机器人对比腹腔镜袖状胃切除术后的住院阿片类药物使用与疼痛控制
该回顾性队列研究纳入2019年10月至2022年8月单中心368例袖状胃切除术患者(腹腔镜286例、机器人82例),比较住院阿片类药物用量与疼痛评分。两组住院吗啡毫克当量中位数及术后疼痛评分无显著差异,腹腔镜组出院时阿片类药物处方比例显著更高(75.2% vs 62.2%,P = .02)。结论认为两种术式住院阿片类药物使用与疼痛评分无差异。
要点
- 腹腔镜组与机器人组住院吗啡毫克当量中位数无显著差异(52.3 vs 40,P = .13)。
- 两组术后第0天和第1天疼痛评分无显著差异。
- 腹腔镜组出院时阿片类药物处方比例显著高于机器人组(75.2% vs 62.2%,P = .02)。
核心结论
- 腹腔镜与机器人袖状胃切除术患者的住院阿片类药物使用或疼痛评分无差异。
研究设计与样本
- 回顾性队列研究,纳入2019年10月至2022年8月单中心接受腹腔镜或机器人袖状胃切除术的减重手术患者,共368例(腹腔镜286例、机器人82例)。
主要发现
- 腹腔镜组平均手术时间显著低于机器人组(87.5 ± 47.3分钟 vs 109.3 ± 30.3分钟;P < .01)。
- 住院吗啡毫克当量总用量中位数两组相似:腹腔镜组52.3(31.5-77.0)vs 机器人组40(24-74.5)(P = .13)。
- 术后平均疼痛评分(满分10分)两组无显著差异:腹腔镜组术后第0天5.2 ± 1.7、第1天4.5 ± 1.7,机器人组术后第0天5.1 ± 2.0、第1天4.4 ± 1.8。
- 出院时阿片类药物处方比例腹腔镜组显著更高(75.2% vs 62.2%;P = .02)。
- 其他临床结局包括住院时间、30天再入院和急诊就诊两组无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: During the past decade, the proportion of bariatric surgery performed robotically has been rising. However, the clinical benefits of the robotic approach over laparoscopy are uncertain. One area in need of further investigation is pain control after robotic versus laparoscopic bariatric surgery. METHODS: A retrospective cohort study was conducted of bariatric surgery patients undergoing laparoscopic or robotic sleeve gastrectomy at a single institution from October 2019 to August 2022. Inpatient opioid use was measured in morphine milliequivalents. Pain scores were collected by the nursing staff. RESULTS: A total of 368 patients were included: 286 laparoscopic and 82 robotic surgery patients. The groups shared similar demographics. For the entire cohort, the mean age was 42 years, the body mass index was 50 kg/m2, and 79% were female. Mean operative time was significantly lower for laparoscopic surgeries (87.5 ± 47.3 minutes vs 109.3 ± 30.3 minutes; P < .01). The median total inpatient morphine milligram equivalents used was similar for both groups: 52.3 (31.5-77.0) for the laparoscopic group versus 40 (24-74.5) for robotic (P = .13). Mean postoperative pain scores (scale out of 10) were not significantly different between groups: 5.2 ± 1.7 (postoperative day 0) and 4.5 ± 1.7 (day 1) for laparoscopic patients versus 5.1 ± 2.0 (day 0) and 4.4 ± 1.8 (day 1) for robotic. The proportion of patients prescribed opioids at discharge was significantly higher for the laparoscopic group (75.2% vs 62.2%; P = .02). Other clinical outcomes, including duration of stay, 30-day readmissions, and visits to the emergency department, were not significantly different. CONCLUSION: There is no difference in inpatient opioid use or pain scores between patients undergoing laparoscopic and robotic sleeve gastrectomy.
引用
- Saleh T, Ford J, Kindel T, et al. Inpatient opioid use and pain control after robotic versus laparoscopic sleeve gastrectomy. Surgery. 2023. PMID: 37981549. doi:10.1016/j.surg.2023.08.064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。